AviadoBio

AviadoBio is a biopharmaceutical development company focused on developing medicines for patients with frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS). The company uses gene therapy platforms and delivery technologies to address medical needs in neurodegenerative diseases.
  • Gene therapy for FTD and ALS
  • Precision drug delivery systems
  • Clinical trials for neurodegenerative diseases

Size
Medium
Phone
N/A
Email
N/A
Locations
20 Water St, E14 9GG
03125432881
Digital Popularity
Social Media
Competitors
LabGenius
LabGenius combines human and machine intelligence to accelerate the discovery of uniquely powerful therapeutic antibodies.
Company Details
AviadoBio is operated by Aviadobio Ltd and is a Active company incorporated on 20 December 2019 with the registered office located in . Aviadobio Ltd was registered 5 years ago.

Status
Active
Size
Unreported
Directors
9
Age
5 years old
Employees
65
Turnover
£2.37M
Total Assets
£58.2M
Cash in Bank
£47.19M
Total Liabilities
-£21.92M

Director • British • Lives in UK • Born in Jun 1972
Director • American • Lives in United States • Born in Apr 1971
Director • Lives in England • Born in Apr 1971
Director • American • Lives in United States • Born in Nov 1961
Director • American • Lives in United States • Born in Sep 1983
Director • American • Lives in United States • Born in Aug 1975
Teams
All
53
Management
22
Research
18
Manufacturing
8
Other
16
Vice President, Regulatory
Vice President Clinical Operations • Joined Mar 2023
Vice President Of Preclinical Research • Joined Mar 2023
Non Executive Director • Joined Sep 2022
Co-Founder And Head Of Vector Science • Joined Jul 2021
Chief Operating Officer • Joined Oct 2022
Chief Scientific Officer • Joined Jan 2024
Executive Assistant • Joined Aug 2022
Director • Joined Dec 2023
Chief Scientific And Clinical Advisor • Joined Mar 2022
Vice President Clinical Operations • Joined Mar 2023
Non Executive Director • Joined Sep 2022
Chief Operating Officer • Joined Oct 2022
Chief Scientific Officer • Joined Jan 2024
Director • Joined Dec 2023
Contracts Manager • Joined Jun 2023
Investor Director • Joined Nov 2021
Head Of Discovery • Joined Feb 2021
Lead Scientist- Transcriptomics Team • Joined Aug 2022
Development Lead, Technical Operations • Joined Feb 2023
Chief Scientific Officer • Joined Jan 2024
Senior Research Associate • Joined May 2021
Senior Research Associate • Joined Jun 2024
Senior Research Associate I • Joined Mar 2023
Senior Research Associate II • Joined Oct 2024
Senior Research Associate II • Joined Sep 2023
Senior Research Associate II • Joined Aug 2024
Senior Research Associate II • Joined Jan 2024
Scientist I • Joined Jul 2022
Research Project Leader • Joined Apr 2022
Quality Assurance Manager • Joined Dec 2023
Senior Director Quality Assurance
Scientist I • Joined Jul 2022
Scientist II • Joined May 2022
Scientist II • Joined Jul 2024
Scientist I • Joined Apr 2022
Scientist I • Joined Feb 2024
Senior Scientist • Joined Oct 2024
Vice President, Regulatory
Head Of Preclinical Research • Joined May 2021
Co-Founder And Head Of Vector Science • Joined Jul 2021
Executive Assistant • Joined Aug 2022
Chief Scientific And Clinical Advisor • Joined Mar 2022
Lead Scientist, Analytical Development • Joined Mar 2022
Director - Process Development • Joined Mar 2023
Senior Manager, Legal Operations • Joined Apr 2022
Director, Analytical And Quality Control • Joined Oct 2021
Senior Director, Discovery R&D • Joined Jan 2025
View 53 members